Connecting brain science & business

Being the driving force in connecting brain science and industry aiming at creating smart solutions for individuals and society.

Committed to improve quality of life through innovation, research and development of diagnostics, therapeutics and preventive measures.

Some of the major medical challenges of the 21st century are related to the increasing age of the population, which will lead to a dramatic increase in the prevalence of some of the most devastating and costly neurological disorders, such as Alzheimer’s disease, Parkinson’s disease, other forms of dementia and stroke. Progress in neuroscience can potentially not only offer effective strategies for prevention, early diagnosis and treatment for these age-related diseases, but also provide a better understanding of serious neuropsychiatric disorders such as epilepsy, headache, schizophrenia, and affective disorders. While this would lead to enormous savings on health care costs, the improved quality of life for those affected cannot be overestimated.

From bench to bedside

A bottleneck in many fields of medical research resides in the translation from basic research to industrial development and clinical practice. We envisage that the progression from discovery to applied medicine would be much facilitated by strengthening the links between basic research and health care providers, in collaboration with industry and commercial partners. By encouraging better integration along the value chain – between the laboratory bench and the patient – one could achieve five major goals:

• Facilitate the flow of ideas and products in the direction of the end users (patients and society).
• Facilitate communication of unmet needs from end users to basic and clinical scientists.
• Improve quality of life for the individual and reduce cost for the society.
• Stimulate the development of a profitable industry with novel products and services.
• Ensure increased political awareness of the importance of basic research in health care.